Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2012

Kirou KA, Gkrouzman E, Chevalier JM, Seshan SV. Antiinflammatory strategies, not just B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis: comment on the article by Rovin et al. Arthritis Rheum. 2012;64(10):3486; author reply 3486.

Flavin R, Finn SP, Choueiri TK, Ingoldsby H, Ring M, Barrett C, et al. RET protein expression in papillary renal cell carcinoma. Urol Oncol. 2012;30(6):900-5.

Westblade LF, Burnham C-. Yeast-like intraleukocytic inclusions in a peripheral smear. Blood. 2012;119(5):1105.

Chen A-, Paik J-, Zhang H, Shukla SA, Mortensen R, Hu J, et al. STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA. Genes Dev. 2012;26(13):1459-72.

Quinn AS, Wu X-, Rand JH, Taatjes DJ. Insights into the pathophysiology of the antiphospholipid syndrome provided by atomic force microscopy. Micron. 2012;43(8):851-62.

Esgueva R, Park K, Kim R, Kitabayashi N, Barbieri CE, Dorsey PJ, et al. Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium. Diagn Mol Pathol. 2012;21(2):61-8.

Wahezi DM, Ilowite NT, Rajpathak S, Rand JH. Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases. J Rheumatol. 2012;39(2):382-8.

Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science. 2012;338(6113):1465-9.

Habegger L, Balasubramanian S, Chen DZ, Khurana E, Sboner A, Harmanci A, et al. VAT: a computational framework to functionally annotate variants in personal genomes within a cloud-computing environment. Bioinformatics. 2012;28(17):2267-9.

Wu X, Zhou J, Rogers AM, Jänne PA, Benedettini E, Loda M, et al. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential. Melanoma Res. 2012;22(2):123-32.